Recombinetics names new execs in leadership switch-up

St. Paul, Minn.-based Recombinetics, a gene editing company, has dubbed Ian Friendly — former executive vice president and COO of U.S. retail for Golden Valley, Minn.-based General Mills — CEO.

Advertisement

Mr. Friendly will replace Recombinetics’ former CEO and founder, Scott Fahrenkrug, PhD, who will transition to the role of executive chairman of the board and chief scientific officer.

Recombinetics has also appointed Tammy Lee Stanoch to chief corporate affairs officer. Ms. Stanoch previously held leadership positions at Minnetonka, Minn.-based Carlson, the Minneapolis-based University of Minnesota Foundation and Atlanta-based Delta Air Lines.

In addition, Recombinetics has named six new members to its board of directors: Mitch Abrahamsen; Perry Hackett, PhD; Wendell King; Mark Kroll, PhD; Paul Olson; and Robert Switz.

More articles on healthcare executive moves:
meQuilibrium names executive VP of sales and business development: 4 things to know
Aetna exec tapped as BCBS of Rhode Island’s first female CEO
Novant adds to executive team: 8 things to know

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.